Meningococcal Vaccine Market Projected to Reach USD 9014 Million by 2034 at a 8.6% of CAGR

The global meningococcal vaccine market is experiencing significant growth, driven by rising incidences of the disease worldwide. As of 2024, the market is estimated to be valued at USD 3,950.2 million and is projected to reach USD 9,014 million by 2034, reflecting a compound annual growth rate (CAGR) of 8.6% over the forecast period from 2024 to 2034. The increasing incidence of meningitis, particularly among vulnerable populations, is one of the key factors propelling this market forward.

Request a Sample Copy of This Report Now: https://www.futuremarketinsights.com/report-sample#5245502d47422d31323532

Data from 2019 highlights the severity of the disease, with approximately 2.51 million cases of meningitis globally, including 1.28 million cases in children under five years old. The high fatality rate of meningococcal diseases has raised widespread concern, prompting a growing demand for vaccination among the general population. As people become more aware of the risks associated with the disease, vaccination rates are steadily rising, contributing to market expansion.

This upward trend is particularly evident in countries with well-established healthcare infrastructures, such as the United States, the United Kingdom, India, and China. These regions are leading the way in both the adoption of meningococcal vaccines and in ongoing public health campaigns to reduce the spread of the disease.

Key Takeaways:

1. The meningococcal vaccine market is expected to grow from USD 3,950.2 million in 2024 to USD 9,014 million by 2034, with a CAGR of 8.6%.
2. The rising global incidence of meningitis, especially in children under five, is fueling demand for meningococcal vaccines.
3. Growing awareness about the severity and fatality of meningococcal disease is driving increased vaccination rates, particularly in countries with strong healthcare systems.
4. Public health initiatives and widespread vaccination campaigns are contributing to the ongoing market growth.

Grab Your Complete Report Instantly – https://www.futuremarketinsights.com/reports/meningococcal-vaccines-market

Growth Drivers

1. Rising Incidence of Meningitis: In 2019, approximately 2.51 million cases of meningitis were reported worldwide, with a significant portion affecting children under five years old. This alarming statistic has heightened awareness and demand for vaccination.
2. Increased Public Awareness: Concerns about the fatality associated with meningococcal disease are prompting more individuals and families to seek vaccination.
3. Government Initiatives: Many countries are incorporating meningococcal vaccines into their national immunization schedules, targeting not only infants and young children but also adolescents and college students.
4. Technological Advancements: The development of new and improved vaccines, including conjugate and multivalent vaccines, is enhancing the effectiveness of immunization efforts.

Leading Meningococcal Vaccines Brands

• GlaxoSmithKline plc
• Pfizer Inc.
• Sanofi Pasteur
• Merck & Co., Inc.
• Novartis AG
• CSL Limited
• Johnson & Johnson
• Bharat Biotech International Limited
• Serum Institute of India Pvt. Ltd.
• Sinovac Biotech Ltd.
• Biological E Limited
• Chongqing Zhifei Biological Products Co., Ltd.
• Beijing Tiantan Biological Products Co., Ltd.
• Hualan Biological Engineering Inc.
• Walvax Biotechnology Co., Ltd.
• Bio-Manguinhos (Fiocruz)
• Hangzhou Jinjiang Group Co., Ltd.
• Shenzhen Kangtai Biological Products Co., Ltd.
• Biomed Pvt. Ltd.
• GlaxoSmithKline Biologicals SA

Key Segments of Market Report

On the basis of product type:

The sector is bifurcated into polysaccharides and conjugates.

Based on the age group:

The industry is segmented into infants, children, adolescents, young adults, and adults.

On account of end users:

The sector is segmented into, pharmacies, community, clinics, public health agencies, and others.

As per region:

The industry is divided into North America, Latin America, Europe, Asia-Pacific, and the Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube